During the past decade, Ege Universitesi Tip Fakultesi conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 11 clinical trials were completed, i.e. on average, 34.4% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 6 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ege Universitesi Tip Fakultesi" #1 sponsor was "Amgen" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Bayer" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ege Universitesi Tip Fakultesi" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Innovative Therapies For Children with Cancer Consortium" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Ege Universitesi Tip Fakultesi" are "Hemophilia A" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Ineffective Erythropoiesis" (2 trials), "Myelofibrosis" (2 trials) and "β-thalassemia" (2 trials). Many other conditions were trialed in "Ege Universitesi Tip Fakultesi" in a lesser frequency.

Most popular intervention types in "Ege Universitesi Tip Fakultesi" are "Drug" (33 trials), "Biological" (8 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Pembrolizumab" (4 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials) and "Rituximab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ege Universitesi Tip Fakultesi" are 36 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ege Universitesi Tip Fakultesi". undefined are not yet recruiting, 14 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Ege Universitesi Tip Fakultesi, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ege Universitesi Tip Fakultesi, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".